ResMed (RMD) PT Lowered to $220 at Mizuho
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $228.42 --0%
Rating Summary:
12 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 23
Rating Summary:
12 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 23
Join SI Premium – FREE
Mizuho analyst Anthony Petrone lowered the price target on ResMed (NYSE: RMD) to $220.00 (from $235.00) while maintaining a Outperform rating.
You May Also Be Interested In
- California Resources (CRC) PT Lowered to $91 at Stephens
- Goldman Sachs Downgrades Tsingtao Brewery Company Limited (168:HK) (TSGTF) to Neutral
- CrowdStrike (CRWD) PT Raised to $280 at Stephens
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
